 WALTHAM, Mass., July 28, 2020 GLOBE NEWSWIRE -- AMAG Pharmaceuticals, Inc. NASDAQ: AMAG today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Dial-in Number U.S.Canada Dial-in Number: 877 412-6083 International Dial-in Number: 702 495-1202 Conference ID: 4548238Replay Dial-in Number: 855 859-2056 Replay International Dial-in Number: 404 537-3406 Conference ID: 4548238A telephone replay will be available from approximately 11:00 a.m. ET on August 6, 2020 through midnight on August 20, 2020The webcast with slides will be accessible through the Investors section of the companys website at A replay of the webcast will be archived on the website for 30 days.About AMAG AMAG is a commercial stage biopharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas. For additional company information, please visit Pharmaceuticals is a registered trademark of AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals Contact: Loraine Spreen 617-866-0303 